The Valley Desk

NCT02044822 · Interventional trial

Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion

Overall registry status Terminated

Phase 2

Conditions B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov